Skip to main content
. 2019 Jun 6;14(6):e0217866. doi: 10.1371/journal.pone.0217866

Fig 3. Comparison of immunoreactivity, in IgM ELISA using SAG2-GRA1-ROP1, SAG2-GRA1-ROP1-AMA1N, AMA1N-SAG2-GRA1-ROP1, AMA1C-SAG2-GRA1-ROP1, andAMA1-SAG2-GRA1-ROP1 chimeric proteins, as well as TLA, with sera from patients with suspected acute (I–IgM +, IgG +, low avidity) and chronic T. gondii infection (II–IgM +, IgG +, high avidity; III–IgM–, IgG +, high avidity), and from seronegative individuals (IV).

Fig 3

The horizontal lines represent the cut-off values.